Achieve Life Sciences Files Q1 2025 10-Q
Ticker: ACHV · Form: 10-Q · Filed: May 13, 2025 · CIK: 949858
| Field | Detail |
|---|---|
| Company | Achieve Life Sciences, Inc. (ACHV) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, life-sciences
TL;DR
ACHV Q1 25 10-Q filed. Convertible debt & stock options in focus.
AI Summary
Achieve Life Sciences, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Sonus Pharmaceuticals Inc. and Oncogenex Pharmaceuticals, Inc., reported on its financial status and business operations. Key financial instruments mentioned include convertible debt and employee stock options.
Why It Matters
This filing provides investors with an update on Achieve Life Sciences' financial health and operational progress during the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a life sciences company, Achieve Life Sciences is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Players & Entities
- ACHIEVE LIFE SCIENCES, INC. (company) — Filer
- 20250331 (date) — Reporting period end date
- 20250513 (date) — Filing date
- ONCOGENEX PHARMACEUTICALS, INC. (company) — Former company name
- SONUS PHARMACEUTICALS INC (company) — Former company name
- us-gaap:ConvertibleDebtMember (financial_instrument) — Mentioned financial instrument
- us-gaap:EmployeeStockOptionMember (financial_instrument) — Mentioned financial instrument
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 13, 2025.
What were some of Achieve Life Sciences' former company names?
Achieve Life Sciences was formerly known as Oncogenex Pharmaceuticals, Inc. and Sonus Pharmaceuticals Inc.
What types of financial instruments are mentioned in the filing?
The filing mentions convertible debt and employee stock options.
What is the Standard Industrial Classification code for Achieve Life Sciences?
The Standard Industrial Classification code for Achieve Life Sciences is 2835, for In Vitro & In Vivo Diagnostic Substances.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding ACHIEVE LIFE SCIENCES, INC. (ACHV).